Jheng-yan H. Wu

Tainan, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 227 publications

Risk of Bone Mineral Density Loss Associated with GLP-1 Receptor Agonists in Overweight COPD Populations [Response to Letter].

Risk of Bone Mineral Density Loss Associated with GLP-1 Receptor Agonists in Overweight COPD Populations [Response to Letter].

Journal: Drug design, development and therapy

Published: July 30, 2026

Comparative Cardiovascular Outcomes of Tirzepatide and Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.

Comparative Cardiovascular Outcomes of Tirzepatide and Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.

Journal: Journal of the American Heart Association

Published: July 17, 2026

Corrigendum to 'Liberal vs. restrictive transfusion strategy for acute brain injury: a meta-analysis with trial sequential analysis of randomized clinical trials'.

Corrigendum to 'Liberal vs. restrictive transfusion strategy for acute brain injury: a meta-analysis with trial sequential analysis of randomized clinical trials'.

Journal: Anaesthesia, critical care & pain medicine

Published: July 13, 2026

Association Between Sacubitril/Valsartan Use and Risk of Major Adverse Cardiovascular Events in Patients With Durable Left Ventricular Assist Devices: A Multi-Institutional Real-World Cohort Study.

Association Between Sacubitril/Valsartan Use and Risk of Major Adverse Cardiovascular Events in Patients With Durable Left Ventricular Assist Devices: A Multi-Institutional Real-World Cohort Study.

Journal: Journal of the American Heart Association

Published: July 10, 2026

Comparative Risk of Respiratory Virus Infections Among Patients with Asthma Treated with Biologic Therapies.

Comparative Risk of Respiratory Virus Infections Among Patients with Asthma Treated with Biologic Therapies.

Journal: QJM : monthly journal of the Association of Physicians

Published: July 04, 2026

Serum zinc deficiency and progression of cardiovascular- kidney-metabolic syndrome.

Serum zinc deficiency and progression of cardiovascular- kidney-metabolic syndrome.

Journal: Frontiers in nutrition

Published: June 15, 2026

Alcohol use disorder and long-term kidney outcomes after acute kidney disease: a retrospective cohort study.

Alcohol use disorder and long-term kidney outcomes after acute kidney disease: a retrospective cohort study.

Journal: The American journal of drug and alcohol abuse

Published: June 08, 2026

Perfusion-guided thrombolysis beyond 4.5 hours for acute ischemic stroke: A time-stratified systematic review and meta-analysis.

Perfusion-guided thrombolysis beyond 4.5 hours for acute ischemic stroke: A time-stratified systematic review and meta-analysis.

Journal: Therapeutic advances in neurological disorders

Published: May 20, 2026

Antecedent glucagon-like peptide-1 receptor agonist use and risk of sepsis-induced cardiomyopathy in type 2 diabetes: a United States real-world active-comparator cohort study.

Antecedent glucagon-like peptide-1 receptor agonist use and risk of sepsis-induced cardiomyopathy in type 2 diabetes: a United States real-world active-comparator cohort study.

Journal: Frontiers in pharmacology

Published: May 10, 2026

Psychiatric safety of methylphenidate in adults with major depressive disorder: a 1-year retrospective cohort study of 6,422 patients.

Psychiatric safety of methylphenidate in adults with major depressive disorder: a 1-year retrospective cohort study of 6,422 patients.

Journal: Psychological medicine

Published: May 05, 2026

Risk of Lymphoma in Patients with Asthma Treated with Dupilumab Compared with Other Biologic Agents: A Retrospective Cohort Study.

Risk of Lymphoma in Patients with Asthma Treated with Dupilumab Compared with Other Biologic Agents: A Retrospective Cohort Study.

Journal: Chest

Published: April 18, 2026

Lower fall and femoral fracture risks with semaglutide and tirzepatide compared with DPP-4 inhibitors in older adults with type 2 diabetes.

Lower fall and femoral fracture risks with semaglutide and tirzepatide compared with DPP-4 inhibitors in older adults with type 2 diabetes.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: April 18, 2026

Showing 1-12 of 227

Last Updated: 09/26/2026